When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XERS - Xeris Pharma pramlintide-insulin candidate shows benefit in mid-stage study
Xeris Pharmaceuticals Inc.
Xeris Pharmaceuticals (NASDAQ:XERS) announces positive results from a Phase 2 clinical trial evaluating candidate XP-3924, a co-formulation of pramlintide and insulin, in adults with type 1 diabetes (T1D).
More news on: Xeris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,